Laboratory Corporation of America(R) Announces 2003 First Quarter Results

Reports Strong Operating Cash Flow of $135 Million; Combined Genomic and Esoteric Testing Revenues Increase 33 Percent BURLINGTON, N.C., Apr 28, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced results for the quarter

LabCorp's Chief Scientific Officer Scheduled to Present Company's Oncology Strategy at Wachovia Securities Cancer Diagnostics Conference

BURLINGTON, N.C., April 9 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Myla Lai-Goldman, M.D., LabCorp Executive Vice President, Chief Scientific Officer and Medical Director, is scheduled to present an overview of the

LabCorp(R) Scheduled to Present at the SunTrust Robinson Humphrey Annual Institutional Investors Conference

BURLINGTON, N.C., April 7 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Bradford T. Smith, executive vice president of public affairs and licensing, is scheduled to speak at the SunTrust Robinson Humphrey Annual Institutional

LabCorp(R) Scheduled to Present at the Banc of America Securities Health Care Conference

BURLINGTON, N.C., Mar 25, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the Banc of America Securities Health Care Conference in

LabCorp(R) Scheduled to Present at the SG Cowen 23rd Annual Health Care Conference

BURLINGTON, N.C., Mar 19, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Bradford T. Smith, executive vice president of public affairs and licensing, is scheduled to speak at the SG COWEN 23RD Annual Health Care

Laboratory Corporation of America(R) Announces 2002 Fourth Quarter and Full Year Results

BURLINGTON, N.C., Feb 18, 2003 /PRNewswire-FirstCall via COMTEX/ -- Strong Results Fueled by Genomic Testing and Substantial Cash Flow Generation Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced results for the quarter and year ended December 31, 2002.

LabCorp(R) Scheduled to Present at the UBS Warburg Global Health Care Services Conference

BURLINGTON, N.C., Feb 4, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the UBS Warburg Global Health Care Services Conference in

LabCorp(R) to Purchase Certain Assets in Northern California From Quest Diagnostics

BURLINGTON, N.C., Feb 4, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) announced that it had executed an agreement to pay $4.5 million in cash to purchase certain assets in Northern California from Quest Diagnostics Incorporated

Laboratory Corporation of America(R) Expands Agreement With Aetna To Add Texas Market

BURLINGTON, N.C., Feb 3, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that it has signed an expanded agreement with Aetna (NYSE: AET) to provide clinical laboratory testing and certain additional services to the

LabCorp(R) Scheduled to Present at the US Bancorp Piper Jaffray Health Care Conference

Will Report Fourth Quarter and Full Year 2002 Results February 18th BURLINGTON, N.C., Jan. 28 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the